WHO ICTRP trial
The innate immune system in atherosclerosis - II
NL-OMON42376 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON42376 |
|---|---|
| Public title | The innate immune system in atherosclerosis - II |
| Scientific title | The innate immune system in atherosclerosis - II - ISA-II |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | arterial wall thickening atherosclerosis;10003216;arterial wall thickening;atherosclerosis |
| Interventions | ;atherosclerosis;inflammation;lipid lowering therapy |
| Registration date | Jan 20, 2016 |
| Target size | 340 |
| Secondary IDs | NL55744.018.15 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: